Alessia Salamone

Milan, 20156, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy.

Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy.

Journal: Neurobiology of disease

Published: April 06, 2022

Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.

Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.

Journal: Nature communications

Published: April 17, 2021

Changes of dimension of EEG/ECoG nonlinear dynamics predict epileptogenesis and therapy outcomes.

Changes of dimension of EEG/ECoG nonlinear dynamics predict epileptogenesis and therapy outcomes.

Journal: Neurobiology of disease

Published: September 28, 2018

Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.

Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.

Journal: Epilepsia

Published: October 17, 2017

High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.

High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.

Journal: Brain, behavior, and immunity

Published: July 07, 2017

Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.

Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.

Journal: Current pharmaceutical design

Published: June 20, 2017

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

Journal: Brain : a journal of neurology

Published: December 12, 2016

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

Journal: Brain : a journal of neurology

Published: December 12, 2016

Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution.

Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution.

Journal: European journal of pharmacology

Published: September 05, 2013

Prolonged nicotine exposure down-regulates presynaptic NMDA receptors in dopaminergic terminals of the rat nucleus accumbens.

Prolonged nicotine exposure down-regulates presynaptic NMDA receptors in dopaminergic terminals of the rat nucleus accumbens.

Journal: Neuropharmacology

Published: August 01, 2013

Dangerous liaisons between beta-amyloid and cholinergic neurotransmission.

Dangerous liaisons between beta-amyloid and cholinergic neurotransmission.

Journal: Current pharmaceutical design

Published: May 10, 2013

Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus.

Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus.

Journal: Frontiers in pharmacology

Published: May 16, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026